Cargando…
Prognostic utility of pretreatment neutrophil-lymphocyte ratio in survival outcomes in localized non-small cell lung cancer patients treated with stereotactic body radiotherapy: Selection of an ideal clinical cutoff point
BACKGROUND AND PURPOSE: Neutrophil-lymphocyte ratio (NLR) has been associated with overall survival (OS) in non-small cell lung cancer (NSCLC). We aimed to assess the utility of NLR as a predictor of lung cancer-specific survival (LCS) and identify an optimal, pretreatment cutoff point in patients w...
Autores principales: | Kotha, Nikhil V., Cherry, Daniel R., Bryant, Alex K., Nalawade, Vinit, Stewart, Tyler F., Rose, Brent S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089768/ https://www.ncbi.nlm.nih.gov/pubmed/33997320 http://dx.doi.org/10.1016/j.ctro.2021.03.010 |
Ejemplares similares
-
Prognostic Utility of Pretreatment Neutrophil-Lymphocyte Ratio in
Advanced Larynx Cancer
por: Kotha, Nikhil V, et al.
Publicado: (2021) -
Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans
por: Kumar, Abhishek, et al.
Publicado: (2021) -
Optimal cutoff of pretreatment neutrophil-to-lymphocyte ratio in head and neck cancer patients: a meta-analysis and validation study
por: Cho, Jae-Keun, et al.
Publicado: (2018) -
Cutoff point of neutrophil-to-lymphocyte ratio for predicting survival in nasopharyngeal carcinoma
por: Setakornnukul, Jiraporn, et al.
Publicado: (2021) -
Evaluating the clinical trends and benefits of low‐dose computed tomography in lung cancer patients
por: Qiao, Edmund M., et al.
Publicado: (2021)